Pharma Contractor ApS Financials, key figures and credit report
Gross profit 2 561.0 kDKK FY 2025 -6.4% vs 2024
EBIT 1 495.4 kDKK FY 2025 -22.5% vs 2024
Net debt 583.8 kDKK FY 2025 +1,764.9% vs 2024
Quick ratio 1.6 FY 2025 -1.7 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 185.45 | 1 889.56 | 2 595.18 | 2 735.41 | 2 561.00 |
| Wages and salaries | - 452.10 | - 875.43 | - 980.70 | ||
| Social security expenses | -61.15 | -73.60 | -29.84 | ||
| Employee benefit expenses | - 789.06 | - 977.93 | |||
| Other operating expenses | -20.45 | - 171.40 | - 197.73 | -60.20 | |
| Total depreciation | -25.11 | -15.71 | -19.67 | -17.69 | -27.50 |
| EBIT | 626.64 | 753.42 | 1 367.24 | 1 928.66 | 1 495.37 |
| Other financial income | 0.00 | ||||
| Other financial expenses | -1.25 | -3.66 | -0.00 | -6.00 | -0.02 |
| Pre-tax profit | 625.39 | 749.76 | 1 367.23 | 1 922.66 | 1 495.35 |
| Income taxes | - 137.59 | - 164.95 | - 300.79 | - 484.35 | - 321.22 |
| Net earnings | 487.80 | 584.81 | 1 066.44 | 1 438.31 | 1 174.13 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 217.31 | 364.80 | |||
| Advance payments and construction in progress | 1.00 | ||||
| Tangible assets total | 1.00 | 217.31 | 364.80 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 196.58 | 230.49 | 274.64 | 301.40 | 12.00 |
| Current amounts owed by group member comp. | 5.13 | 132.33 | 1 019.80 | 1 117.95 | 1 833.89 |
| Prepayments and accrued income | 55.00 | ||||
| Current other receivables | 115.33 | 93.09 | |||
| Current deferred tax assets | 160.80 | 67.17 | 13.79 | ||
| Short term receivables total | 362.52 | 417.82 | 1 361.61 | 1 534.68 | 1 952.77 |
| Cash and bank deposits | 426.60 | 377.60 | 276.66 | 272.33 | 122.46 |
| Cash and cash equivalents | 426.60 | 377.60 | 276.66 | 272.33 | 122.46 |
| Balance sheet total (assets) | 789.12 | 796.42 | 1 638.27 | 2 024.32 | 2 440.03 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 85.00 | 1 065.44 | 1 438.31 | 1 174.05 | |
| Other reserves | -68.05 | ||||
| Retained earnings | 137.59 | - 170.00 | -1 066.44 | -1 438.31 | -1 174.05 |
| Profit of the financial year | 487.80 | 584.81 | 1 066.44 | 1 438.31 | 1 174.13 |
| Shareholders equity total | 665.39 | 539.81 | 1 105.44 | 1 478.31 | 1 146.08 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 338.89 | ||||
| Current trade creditors | 0.75 | 10.00 | |||
| Current owed to participating | 4.89 | 3.57 | 3.67 | 237.26 | 367.34 |
| Short-term deferred tax liabilities | 142.53 | 300.79 | 335.02 | ||
| Other non-interest bearing current liabilities | 118.09 | 100.50 | 228.37 | 308.74 | 252.70 |
| Current liabilities total | 123.73 | 256.61 | 532.83 | 546.00 | 1 293.95 |
| Balance sheet total (liabilities) | 789.12 | 796.42 | 1 638.27 | 2 024.32 | 2 440.03 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated